• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Scroll to next section Scroll to next section

Non-Sponsored Content

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail


MEDICAL NEWS ASIA

PolyU Researchers Develop Novel Self-fitting Scaffold for Bone-Regeneration

By: scienterrific | Last updated: 16 August 2018 | In: China, Medical News Asia

Article Keywords

bone-regeneration, fractures, nanotechnology, osteoporosis, PolyU

HONG KONG, August 15, 2018 /PRNewswire/ — A group of researchers from the Hong Kong Polytechnic University (PolyU) in close collaboration with Sichuan University have successfully designed and manufactured a novel bone scaffold that can be safely implanted into bone defects, induce bone-regeneration, and enhance the recovery of bone injuries and fractures.

Bone-fracturing is becoming an increasing global health concern, particularly in ageing societies. Therefore, enhancing bone-grafting methods and streamlining the induction of bone-regeneration can relieve patients from suffering and decrease the overall health-expenditure for society.

 

A recent study revealed that in Hong Kong alone the annual number of new cases of osteoporosis-related hip-fractures, currently 9,590, will triple by 2050. Malaysia and Singapore are facing a 3.5-fold increase.

 

In spite of the innate regenerative capacity of the bone, bone-grafting surgeries (both autografts and allografts) are often required to achieve bone-regeneration after severe fractures or procedures, such as the resection of bone tumours.

The self-fitting scaffold by the PolyU researchers led by Professor Hu Jinlian, Dr Xie Ruiqi from the Institute of Textiles and Clothes, and Dr Guo Xia from the Division of Rehabilitation Sciences, is made of made of polyurethane shape memory foam and hydroxyapatite (the principal mineral element of bone tissue) nanoparticles. The product compacts at 0°C and for injection into the bone. Once injected, the original shape can be completely recovered by triggering it with 40°C saline, a temperature matching that of the human body.

The novel scaffold fulfils two major requirements; it can act as a mould to achieve speedy tissue regeneration and that it can be utilised during a minimally invasive surgery, thus reducing the duration of hospitalisation and risk of secondary infections.

 

Study evidence

The scaffold was tested in an animal trial, including 18 rabbits with bilateral femoral bone defects. The resulting 36 lesions were then divided into an experimental group in which lesions were filled with the novel scaffold and a control group which was left unfilled.

 

“The results [of the animal studies] show that our scaffold has overcome the disadvantages of regular polymer scaffolds, and has excellent prospective for bone regeneration,”

~Professor Hu Jinlian

 

The invention showed to increase the formation of osteoblasts and blood vessels. In the rabbit study, at 12 weeks after the surgery, bone tissue ingrowth in volume was faster in the experimental group (46%) when compared to the control group (24%). Moreover, the experimental group displayed a 4-fold number of neovascular buds growing on the scaffolds when compared to the control group. In the experimental group, 5% of the bone surface was covered by osteoblasts, whereas in the control group, osteoblasts were nearly unseen.

 

Features of PolyU’s bone scaffold

The novel scaffold developed of shape memory polyurethane foam (a sort of plastic material) and hydroxyapatite (HA) nano-particles is characterized by its outstanding self-fitting effect. It has a porous structure with interconnected pores which allow for cell migration and formation of new tissues. The material’s mechanical strength is similar to the trabecular bone.

 

References

1. Cheung, C. L., Ang S. B., Chadha M., Chow S. L., Chung Y. S., Hew F. L., Jaisamrarn U., Ng H., Takeuchi Y., Wu C. H., Xia W., Yu J., Fujiwa S. (2018). An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies trial, Osteoporosis and Sarcopenia (four) 1, 16. doi.org/10.1016/j.afos.2018.03.003

2. Tests have been performed on scaffolds produced with 1%, three%, five%, 7% of HA nano-particles in content material. The figures cited in this press release are referring to scaffold with 7% HA nanoparticles.


Newsletter Sign-Up

Do you like our content? Subscribe to our non-intrusive newsletter today! We promise we won’t be spammy.

YOU MAY ALSO LIKE

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2018 MediPaper Medical Communications Ltd. – PolyU Researcher Develop Novel Self-fitting Scaffold for Bone-Regeneration

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail

YOU MAY ALSO LIKE

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© Copyright 2018 MediPaper Medical Communications Ltd. – PolyU Researcher Develop Novel Self-fitting Scaffold for Bone-Regeneration

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Link to: Pan-EGFR TKI pirotinib has commenced into Phase II clinical testing in China Link to: Pan-EGFR TKI pirotinib has commenced into Phase II clinical testing in China Pan-EGFR TKI pirotinib has commenced into Phase II clinical testing in Chin... Link to: Lenvatinib FDA approved for 1st-line treatment of HCC Link to: Lenvatinib FDA approved for 1st-line treatment of HCC Lenvatinib FDA approved for 1st-line treatment of HCC
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only